From our work and that of others it is clear that hyperplasia occurs at all anastomoses between a prosthetic graft and a host artery. Many events are occurring at these anastomoses, and consequently it has been difficult to determine precisely any cause and effect relationships. At the anastomosis, there is, in essence, an ongoing wound healing response. In this case, the wound healing is complicated by the presence of a foreign body and a variety of stresses, i.e. hoop stress, normal stress, and shear stress. The foreign body response is in itself poorly understood but is probably a function of the material structure and warrants continued investigation. Sumpio et aL5 and others have demonstrated the effects of pulsatile stress on cell growth.6 The hyperplasia itself consists of modified smooth muscle cells or myofibroblasts whose migration, growth and secretory patterns are influenced by a myriad of growth factors and cytokines in a resilient biologic response system.' The most common cause of delayed failure of prosOur approach has been to focus on one small part of thetic arterial grafts is the development of neointimal this and that is the mechanism leading to augmentation of hyperplasia at the anastomoses as originally described by hyperplasia at the outSlow anastomosis. It is our hypothesis DeWeese.' Because these lesions are restricted to the that the blood-materials interaction produces substances anastomotic site, we became interested in the possibility that modify the cellular response. Shortly after implantathat mechanical factors at the anastomosis played a role.
tion of a prosthetic device, regardless of the substrate After developing plastic models of various anastomotic material, the surface rapidly becomes coated with proteins configurations, we were able to demonstrate ringlike areas and ultimately develops a pseudointima consisting of fibrin of separated flow at the end-to-side anastomosis.' These with enmeshed red cells. The surface itself activates areas of flow separation occur at both inflow and outflow
Hagemann factor, initiating a cascade of sequences the end anastomoses and are highly dependent upon the angle of result of which is the activation of three important anastomosis and the flow split between the runoffvessels."* components: (1) the coagulation cascade with the producBased on what we had learned from the plastic models, we tion of fibrin by thrombin, (2) the activation of platelets devised an animal model in which we could control the directly by the surface or indirectly through thrombin, and presence or absence of flow separation at the anastomoses.3 (3) production of plasmin, which in addition to its lytic Using Dacron grafts, we were unable to demonstrate a activity, also initiates the complement cascade with activarelationship between the presence or absence of flow tion of white blood cells.' Thus the blood-materials separation and the development of anastomotic hyperplainteraction is extremely complex with the production of sia. However, we did note a consistently greater amount of hyperplasia at the distal anastomosis as compared with the proximal anastomosis. These observations led us to our current hypothesis that interaction of blood with the surface of the conduit produces substances that aggravate or augment the hyperplastic response at the outflow or downstream anastomosis.
For that reason, we referred to the lesion as downstream anastomotic hyperplasia and identified it as the primary mechanism of failure of Dacron grafts in our modeL3 We then considered the role of the underlying prosthetic material and designed a study to determine whether there was a significant difference between Dacron and polytetrafluoroethylene (PTFE) in the development of downstream anastomotic hyperplasia. In this study we used end-to-end anastomoses in the carotid position to minimize the possibility that any flow disturbances were playing a role. That study confirmed an increase in anastomotic hyperplasia at the downstream anastomosis for both Dacron and PTFE, and we concluded that this is probably the final common pathway for failure of all prosthetic arterial grafts.'
